29.09.2022 • NewsBorealisRosierfertilizer

Borealis Sells Rosier Stake to Yildirim

Borealis has agreed to sell its 98.09% stake in Belgian fertilizer producer Rosier to Turkey’s Yildirim Group. The proposed deal puts an enterprise value of €35 million on Rosier.

The Austrian chemicals and plastics group confirmed last August that it intended to launch a squeeze out offer for Rosier’s remaining shares as part of a rescue package for the firm, which has been struggling financially from tough market conditions and the impact on its business from the war in Ukraine.

The deal with Yildirim is subject to certain regulatory approvals, as well as Borealis concluding the squeeze-out. Boreais said it wants to focus on providing sustainable solutions for its core activities of polyolefins and base chemicals.

Headquartered in Istanbul, Borealis said Yildirim is one of the fastest-growing Turkish industrial conglomerates. The family-owned group is active in several industry sectors, including fertilizers and chemicals.

Yilfert Holding regards itself as the leading producer of calcium ammonium nitrate (CAN) fertilizer and ammonia in Turkey, and the country’s third-largest trader of fertilizers and chemicals (CAN, ammonium nitrate, diammonium phosphate, ammonium sulfate and urea).

Yildirim also owns Gemlik Gubre, another major Turkish fertilizer producer with an annual capacity of 600,000 t/y.

Author: Elaine Burridge, Freelance Journalist

© Borealis
© Borealis

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.